Stock DNA
Commodity Chemicals
INR 459 Cr (Micro Cap)
NA (Loss Making)
37
0.36%
0.38
-0.09%
1.26
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-02-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 18 Nov 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in financial performance and valuation metrics. The upgrade is primarily driven by improvements in technical indicators, while fundamental concerns remain largely unchanged.
Read More
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 November 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read More
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 September 2026, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 31 October 2026, providing investors with the latest data to understand the rationale behind this recommendation.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Oct-2026 | Source : BSESubmission of Newspaper Clippings of Un-Audited Financial Results for the quarter and half year ended 30th September 2026 approved vide board meeting held on 28th October 2026
Announcement under Regulation 30 (LODR)-Change in Management
28-Oct-2026 | Source : BSESubmission of approval by the Board wrt. designating Chief Operating Officer (Senior Management Personnel) in the Company at its meeting held on 28th October 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 28.10.2026
28-Oct-2026 | Source : BSEIn the Board meeting held today i.e. 28th October 2026 the Board has approved Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2026
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 02 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.6%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 3.35% vs -2.17% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -136.82% vs 1,093.75% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025
YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025